BTG1 anticorps (AA 22-171)
Aperçu rapide pour BTG1 anticorps (AA 22-171) (ABIN6137683)
Antigène
Voir toutes BTG1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 22-171
-
Séquence
- ISKFLRTKGL TSERQLQTFS QSLQELLAEH YKHHWFPEKP CKGSGYRCIR INHKMDPLIG QAAQRIGLSS QELFRLLPSE LTLWVDPYEV SYRIGEDGSI CVLYEASPAG GSTQNSTNVQ MVDSRISCKE ELLLGRTSPS KNYNMMTVSG
-
Réactivité croisée
- Humain
-
Attributs du produit
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 22-171 of human BTG1 (NP_001722.1).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000,IF,1:50 - 1:100
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- BTG1 (B-Cell Translocation Gene 1, Anti-Proliferative (BTG1))
-
Autre désignation
- BTG1
-
Sujet
- This gene is a member of an anti-proliferative gene family that regulates cell growth and differentiation. Expression of this gene is highest in the G0/G1 phases of the cell cycle and downregulated when cells progressed through G1. The encoded protein interacts with several nuclear receptors, and functions as a coactivator of cell differentiation. This locus has been shown to be involved in a t(8,12)(q24,q22) chromosomal translocation in a case of B-cell chronic lymphocytic leukemia.,BTG1,APRO2,Epigenetics & Nuclear Signaling,Cell Biology & Developmental Biology,Apoptosis,Cell Cycle,Cell cycle inhibitors,Cell differentiation,Cardiovascular,Angiogenesis,BTG1
-
Poids moléculaire
- 19 kDa
-
ID gène
- 694
-
UniProt
- P62324
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-